Clearpoint Neuro 주식 주식분석 | 주식가격 | 뉴스 | CLPT | US18507C1036 | A2PZ3E

날짜	Clearpoint Neuro 주식 가격
	13.46 undefined
	12.06 undefined
	11.98 undefined
	12.04 undefined
	12.41 undefined
	11.61 undefined
	11.39 undefined
	12.13 undefined
	11.62 undefined
	10.80 undefined
	11.21 undefined
	11.12 undefined
	10.91 undefined
	10.81 undefined
	11.21 undefined
	11.19 undefined
	11.11 undefined
	11.27 undefined
	11.40 undefined
	11.53 undefined

날짜	Clearpoint Neuro 매출	Clearpoint Neuro EBIT	Clearpoint Neuro 이익
2026e	59.47 백만 undefined	-15.61 백만 undefined	-14.92 백만 undefined
2025e	39.77 백만 undefined	-18.17 백만 undefined	-17.17 백만 undefined
2024e	31.95 백만 undefined	-19.33 백만 undefined	-18.91 백만 undefined
2023	23.96 백만 undefined	-22.45 백만 undefined	-22.09 백만 undefined
2022	20.55 백만 undefined	-16.33 백만 undefined	-16.44 백만 undefined
2021	16.3 백만 undefined	-13.37 백만 undefined	-14.41 백만 undefined
2020	12.83 백만 undefined	-6.22 백만 undefined	-6.78 백만 undefined
2019	11.22 백만 undefined	-4.59 백만 undefined	-5.54 백만 undefined
2018	7.35 백만 undefined	-5.25 백만 undefined	-6.16 백만 undefined
2017	7.38 백만 undefined	-6.34 백만 undefined	-7.17 백만 undefined
2016	5.75 백만 undefined	-7.49 백만 undefined	-8.07 백만 undefined
2015	4.59 백만 undefined	-7.72 백만 undefined	-8.45 백만 undefined
2014	3.6 백만 undefined	-9.66 백만 undefined	-4.52 백만 undefined
2013	3.93 백만 undefined	-7.47 백만 undefined	-7.09 백만 undefined
2012	5.06 백만 undefined	-4.01 백만 undefined	-5.88 백만 undefined
2011	3.82 백만 undefined	-5.92 백만 undefined	-8.31 백만 undefined
2010	2.67 백만 undefined	-9.52 백만 undefined	-9.45 백만 undefined
2009	2.6 백만 undefined	-7.06 백만 undefined	-7.16 백만 undefined
2008	1.95 백만 undefined	-5.23 백만 undefined	-5.43 백만 undefined
2007	0 undefined	-3.51 백만 undefined	-3.7 백만 undefined
2006	0 undefined	-1.14 백만 undefined	-800,000 undefined
2005	300,000 undefined	-920,000 undefined	-950,000 undefined

	매출	EBIT	이익
2005	300,000 USD	-920,000 USD	-950,000 USD
2006	0 USD	-1.14 백만 USD	-800,000 USD
2007	0 USD	-3.51 백만 USD	-3.7 백만 USD
2008	1.95 백만 USD	-5.23 백만 USD	-5.43 백만 USD
2009	2.6 백만 USD	-7.06 백만 USD	-7.16 백만 USD
2010	2.67 백만 USD	-9.52 백만 USD	-9.45 백만 USD
2011	3.82 백만 USD	-5.92 백만 USD	-8.31 백만 USD
2012	5.06 백만 USD	-4.01 백만 USD	-5.88 백만 USD
2013	3.93 백만 USD	-7.47 백만 USD	-7.09 백만 USD
2014	3.6 백만 USD	-9.66 백만 USD	-4.52 백만 USD
2015	4.59 백만 USD	-7.72 백만 USD	-8.45 백만 USD
2016	5.75 백만 USD	-7.49 백만 USD	-8.07 백만 USD
2017	7.38 백만 USD	-6.34 백만 USD	-7.17 백만 USD
2018	7.35 백만 USD	-5.25 백만 USD	-6.16 백만 USD
2019	11.22 백만 USD	-4.59 백만 USD	-5.54 백만 USD
2020	12.83 백만 USD	-6.22 백만 USD	-6.78 백만 USD
2021	16.3 백만 USD	-13.37 백만 USD	-14.41 백만 USD
2022	20.55 백만 USD	-16.33 백만 USD	-16.44 백만 USD
2023	23.96 백만 USD	-22.45 백만 USD	-22.09 백만 USD
2024e	31.95 백만 USD	-19.33 백만 USD	-18.91 백만 USD
2025e	39.77 백만 USD	-18.17 백만 USD	-17.17 백만 USD
2026e	59.47 백만 USD	-15.61 백만 USD	-14.92 백만 USD

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

9.92	2.57	1.58	0.15	1.62	3.52	9.24	5.41	3.32	9.29	3.1	5.7	20.1	54.11	37.49	23.14
0.01	0	0.03	0.4	0.45	0.77	0.47	1.22	0.87	0.95	1.23	1.09	1.88	2.34	2.67	3.21
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0.57	1.61	0.97	0.9	1.48	1.97	1.81	1.77	2.31	2.11	3.24	3.24	4.94	9.3	7.91
0.02	0.06	0.02	0.02	0.11	0.17	0.03	0.1	0.14	0.19	0.21	0.36	0.24	0.51	1.72	1.91
9.95	3.2	3.24	1.54	3.08	5.94	11.71	8.54	6.1	12.74	6.65	10.39	25.46	61.9	51.18	36.17
0.86	0.99	0.98	1.22	1.29	0.9	0.48	0.44	0.33	0.27	0.38	0.82	3.06	2.78	2.7	4.95
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0.06	0.05	0.03	0	0	0	0	0	0	0	0	0.35	0.27	1.03	1.04
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.14	0.43	0.3	0.25	1.19	1.03	1.2	0.96	0.99	0.88	0.82	0.72	0.65	0.64	0.58	0.5
1	1.48	1.33	1.5	2.48	1.93	1.68	1.4	1.32	1.15	1.2	1.54	4.06	3.69	4.31	6.49
10.95	4.68	4.57	3.04	5.56	7.87	13.39	9.94	7.42	13.89	7.85	11.93	29.52	65.59	55.49	42.66

8.02	8.02	8.13	8.13	0.48	0.59	0.75	0.02	0.04	0.11	0.11	0.15	0.17	0.24	0.25	0.25
25.65	25.79	29.69	31.5	59	65.33	76.43	83.72	93.08	106.76	108.6	117.17	121.73	182.48	187.01	193.38
-34.86	-42.02	-51.48	-59.79	-65.67	-72.75	-77.28	-85.73	-93.87	-101.04	-107.2	-112.74	-119.52	-133.93	-150.37	-172.46
-0.57	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-1.76	-8.21	-13.66	-20.16	-6.19	-6.83	-0.1	-1.99	-0.75	5.83	1.51	4.58	2.38	48.79	36.89	21.17
0.74	0.47	3.5	4.04	1.96	1.38	1	0.7	1.55	0.76	0.5	0.97	0.3	0.43	0.27	0.39
0.29	1.19	2.55	4	1.46	0.52	1.62	1.96	1.12	1.29	1.16	1.85	2.34	3.65	5.45	4.42
2.6	3.88	2.6	6.55	2.89	8.19	2.3	0.77	0.35	0.35	0.35	1.02	0.56	0.68	1.07	2.61
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	4.22	0	2	0	0	0	0	0	0
3.63	5.54	8.65	14.59	6.31	10.09	4.92	7.65	3.02	4.4	2.01	3.84	3.2	4.76	6.79	7.43
0	2.37	6.57	7.88	6.53	4.08	7.69	3.72	4.49	2.92	3.48	2.07	21.28	9.84	9.89	9.95
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
9.09	6.65	4.68	2.4	0.57	0.53	0.88	0.54	0.65	0.75	0.86	1.43	2.66	2.2	1.92	4.11
9.09	9.02	11.25	10.28	7.1	4.61	8.57	4.26	5.14	3.67	4.34	3.5	23.94	12.04	11.81	14.06
12.72	14.56	19.9	24.87	13.41	14.7	13.49	11.91	8.16	8.07	6.35	7.34	27.14	16.8	18.6	21.49
10.96	6.35	6.24	4.71	7.22	7.87	13.39	9.92	7.41	13.9	7.86	11.92	29.52	65.59	55.49	42.66

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
-3	-5	-7	-9	-8	-5	-7	-4	-8	-8	-7	-6	-5	-6	-14	-16	-22
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	12	-2	0	0	-6	-2	1	-1	0	-1	0	0	-2	-1	-4	0
0	0	0	1	3	6	2	-3	2	2	3	3	2	2	5	8	14
0	0	0	0	0	0	0	0	0	0	0	0	0	1,000	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-2	7	-9	-7	-6	-7	-7	-7	-8	-5	-5	-4	-2	-7	-12	-16	-13
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1	-1
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-10	8
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-9	10
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	3	0	4	3	0	3	0	0	0	-2	-2	-1	0	0	0
0	0	0	0	0	5	9	9	4	3	11	0	7	24	47	0	0
0	0	2	6	4	9	9	13	4	3	11	-1	5	22	46	0	0
0	0	0	6	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-2	6	-7	0	-1	1	1	5	-3	-2	5	-6	2	14	34	-26	-4
-3.05	6.31	-9.76	-7.77	-6.27	-7.56	-7.95	-7.3	-8.72	-5.92	-6.02	-4.69	-3.01	-8.29	-12.87	-17.32	-14.77
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Clearpoint Neuro 브루토마진	Clearpoint Neuro 이익 마진	Clearpoint Neuro EBIT-마진	Clearpoint Neuro 이익 마진
2026e	56.83 %	-26.24 %	-25.09 %
2025e	56.83 %	-45.69 %	-43.19 %
2024e	56.83 %	-60.5 %	-59.18 %
2023	56.83 %	-93.7 %	-92.21 %
2022	65.84 %	-79.46 %	-80 %
2021	69.26 %	-82.02 %	-88.4 %
2020	71.08 %	-48.48 %	-52.84 %
2019	65.78 %	-40.91 %	-49.38 %
2018	66.94 %	-71.43 %	-83.81 %
2017	60.7 %	-85.91 %	-97.15 %
2016	54.09 %	-130.26 %	-140.35 %
2015	56.86 %	-168.19 %	-184.1 %
2014	46.67 %	-268.33 %	-125.56 %
2013	63.87 %	-190.08 %	-180.41 %
2012	88.93 %	-79.25 %	-116.21 %
2011	82.72 %	-154.97 %	-217.54 %
2010	99.25 %	-356.55 %	-353.93 %
2009	100 %	-271.54 %	-275.38 %
2008	100 %	-268.21 %	-278.46 %
2007	56.83 %	0 %	0 %
2006	56.83 %	0 %	0 %
2005	56.83 %	-306.67 %	-316.67 %

	브루토마진	EBIT-마진	이익 마진
2005	56.83 %	-306.67 %	-316.67 %
2006	56.83 %	0 %	0 %
2007	56.83 %	0 %	0 %
2008	100 %	-268.21 %	-278.46 %
2009	100 %	-271.54 %	-275.38 %
2010	99.25 %	-356.55 %	-353.93 %
2011	82.72 %	-154.97 %	-217.54 %
2012	88.93 %	-79.25 %	-116.21 %
2013	63.87 %	-190.08 %	-180.41 %
2014	46.67 %	-268.33 %	-125.56 %
2015	56.86 %	-168.19 %	-184.1 %
2016	54.09 %	-130.26 %	-140.35 %
2017	60.7 %	-85.91 %	-97.15 %
2018	66.94 %	-71.43 %	-83.81 %
2019	65.78 %	-40.91 %	-49.38 %
2020	71.08 %	-48.48 %	-52.84 %
2021	69.26 %	-82.02 %	-88.4 %
2022	65.84 %	-79.46 %	-80 %
2023	56.83 %	-93.7 %	-92.21 %
2024e	56.83 %	-60.5 %	-59.18 %
2025e	56.83 %	-45.69 %	-43.19 %
2026e	56.83 %	-26.24 %	-25.09 %

날짜	Clearpoint Neuro 주당 매출	Clearpoint Neuro EBIT 당 주식	Clearpoint Neuro 주당 이익
2026e	2.15 undefined	0 undefined	-0.54 undefined
2025e	1.44 undefined	0 undefined	-0.62 undefined
2024e	1.16 undefined	0 undefined	-0.69 undefined
2023	0.97 undefined	-0.91 undefined	-0.9 undefined
2022	0.85 undefined	-0.68 undefined	-0.68 undefined
2021	0.79 undefined	-0.64 undefined	-0.7 undefined
2020	0.81 undefined	-0.39 undefined	-0.43 undefined
2019	0.85 undefined	-0.35 undefined	-0.42 undefined
2018	0.67 undefined	-0.48 undefined	-0.56 undefined
2017	0.95 undefined	-0.82 undefined	-0.93 undefined
2016	2.09 undefined	-2.72 undefined	-2.93 undefined
2015	2.44 undefined	-4.11 undefined	-4.49 undefined
2014	2.43 undefined	-6.53 undefined	-3.05 undefined
2013	2.75 undefined	-5.22 undefined	-4.96 undefined
2012	5.01 undefined	-3.97 undefined	-5.82 undefined
2011	9.55 undefined	-14.8 undefined	-20.78 undefined
2010	15.71 undefined	-56 undefined	-55.59 undefined
2009	20 undefined	-54.31 undefined	-55.08 undefined
2008	15 undefined	-40.23 undefined	-41.77 undefined
2007	0 undefined	-27 undefined	-28.46 undefined
2006	0 undefined	-9.5 undefined	-6.67 undefined
2005	2.5 undefined	-7.67 undefined	-7.92 undefined

	주당 매출	EBIT 당 주식	주당 이익
2005	2.5 USD	-7.67 USD	-7.92 USD
2006	0 USD	-9.5 USD	-6.67 USD
2007	0 USD	-27 USD	-28.46 USD
2008	15 USD	-40.23 USD	-41.77 USD
2009	20 USD	-54.31 USD	-55.08 USD
2010	15.71 USD	-56 USD	-55.59 USD
2011	9.55 USD	-14.8 USD	-20.78 USD
2012	5.01 USD	-3.97 USD	-5.82 USD
2013	2.75 USD	-5.22 USD	-4.96 USD
2014	2.43 USD	-6.53 USD	-3.05 USD
2015	2.44 USD	-4.11 USD	-4.49 USD
2016	2.09 USD	-2.72 USD	-2.93 USD
2017	0.95 USD	-0.82 USD	-0.93 USD
2018	0.67 USD	-0.48 USD	-0.56 USD
2019	0.85 USD	-0.35 USD	-0.42 USD
2020	0.81 USD	-0.39 USD	-0.43 USD
2021	0.79 USD	-0.64 USD	-0.7 USD
2022	0.85 USD	-0.68 USD	-0.68 USD
2023	0.97 USD	-0.91 USD	-0.9 USD
2024e	1.16 USD	0 USD	-0.69 USD
2025e	1.44 USD	0 USD	-0.62 USD
2026e	2.15 USD	0 USD	-0.54 USD

Segmente	2023	2022	2021	2020	2019	2018
Product revenue	-	12.79 백만 USD	11.91 백만 USD	-	-	-
Service and other revenue	-	7.76 백만 USD	4.39 백만 USD	-	-	-
Product Revenue	-	-	-	-	9.48 백만 USD	-
Product Revenues	-	-	-	8.79 백만 USD	-	-
Service and Other Revenues	-	-	-	4.04 백만 USD	1.74 백만 USD	-
Functional Neurosurgery Navigation and Therapy - Disposable Products	-	7.59 백만 USD	7.7 백만 USD	6.27 백만 USD	-	-
Subtotal - Functional Neurosurgery Navigation and Therapy	-	9.12 백만 USD	8.07 백만 USD	-	-	-
Subtotal - Biologics and Drug Delivery	-	9.12 백만 USD	6.8 백만 USD	-	-	-
Service and other revenue	13.35 백만 USD	-	-	-	-	-
Product revenue	10.6 백만 USD	-	-	-	-	-
Product - Product Revenue	-	-	-	-	9.48 백만 USD	-
Biologics and Drug Delivery - Disposable Products	-	3.69 백만 USD	3.35 백만 USD	1.47 백만 USD	-	-
Biologics and Drug Delivery - Services	-	-	3.44 백만 USD	3.58 백만 USD	-	-
Product - Functional Neurosurgery	-	-	-	-	6.88 백만 USD	-
Product Revenue	-	-	-	-	-	6.69 백만 USD
Functional Neurosurgery Navigation and Therapy	-	-	-	6.3 백만 USD	-	-
Biologics And Drug Delivery - Services And License Fees	-	5.43 백만 USD	-	-	-	-
Functional Neurology	-	-	-	-	-	5.31 백만 USD
Biologics and Drug Delivery Revenue	-	-	-	5.04 백만 USD	-	-
Subtotal - Capital Equipment and Software Revenue	-	2.31 백만 USD	1.43 백만 USD	-	-	-
Capital Equipment and Software - Systems and Software Products	-	1.51 백만 USD	864,000 USD	1.05 백만 USD	-	-
Functional Neurosurgery Navigation and Therapy - Services	-	1.54 백만 USD	375,000 USD	25,000 USD	-	-
Capital Equipment and Software - Services	-	795,000 USD	569,000 USD	440,000 USD	-	-
Services - Service Revenue	-	-	-	-	1.74 백만 USD	-
Capital Equipment and Software Revenue	-	-	-	1.49 백만 USD	-	-
Product - Biologics and Drug Delivery	-	-	-	-	1.46 백만 USD	-
Product - Capital Equipment	-	-	-	-	1.04 백만 USD	-
Biologics And Drug Delivery	-	-	-	-	-	951,940 USD
Services - Biologics and Drug Delivery	-	-	-	-	889,702 USD	-
Service and Other Revenues	-	-	-	-	-	668,246 USD
Services - Capital Equipment and Other	-	-	-	-	625,870 USD	-
Capital Equipment	-	-	-	-	-	420,039 USD
Capital Equipment and Other	-	-	-	-	-	393,023 USD
Remaining Performance Obligations Capital Equipment-Related Service Revenue Member]	-	-	-	-	-	303,912 USD
Service - Therapy	-	-	-	-	225,000 USD	-
Capital Equipment-Related Service Revenue Member]	-	-	-	-	-	142,605 USD
Products - Therapy	-	-	-	-	96,925 USD	-
Remaining Performance Obligations Capital Equipment-Related Service Revenue	-	-	-	-	1.1 백만 USD	-
Capital Equipment-Related Service Revenue	-	-	-	500,000 USD	228,000 USD	-
Remaining Performance Obligation Related to Capital Equipment and Software-Related Service Agreements	-	-	-	500,000 USD	-	-

	주식 수량
2005	120,000 Aktien
2006	120,000 Aktien
2007	130,000 Aktien
2008	130,000 Aktien
2009	130,000 Aktien
2010	170,000 Aktien
2011	400,000 Aktien
2012	1.01 백만 Aktien
2013	1.43 백만 Aktien
2014	1.48 백만 Aktien
2015	1.88 백만 Aktien
2016	2.75 백만 Aktien
2017	7.74 백만 Aktien
2018	10.93 백만 Aktien
2019	13.16 백만 Aktien
2020	15.85 백만 Aktien
2021	20.73 백만 Aktien
2022	24.18 백만 Aktien
2023	24.61 백만 Aktien
2024e	24.61 백만 Aktien
2025e	24.61 백만 Aktien
2026e	24.61 백만 Aktien

EPS-예상치	EPS-실제	보고 분기
-0.2	-0.16 (20.24 %)	2024 Q2
-0.19	-0.16 (17.44 %)	2024 Q1
-0.21	-0.19 (8.39 %)	2023 Q4
-0.26	-0.2 (21.57 %)	2023 Q3
-0.19	-0.29 (-49.64 %)	2023 Q2
-0.19	-0.23 (-21.89 %)	2023 Q1
-0.2	-0.18 (11.76 %)	2022 Q4
-0.19	-0.15 (22.6 %)	2022 Q3
-0.19	-0.18 (3.33 %)	2022 Q2
-0.2	-0.17 (16.67 %)	2022 Q1
-0.19	-0.2 (-3.2 %)	2021 Q4
-0.16	-0.18 (-10.29 %)	2021 Q3
-0.14	-0.17 (-23.46 %)	2021 Q2
-0.15	-0.13 (12.1 %)	2021 Q1
-0.13	-0.09 (32.13 %)	2020 Q4
-0.14	-0.09 (36.97 %)	2020 Q3
-0.16	-0.11 (32.6 %)	2020 Q2
-0.18	-0.13 (29.19 %)	2020 Q1
-0.82	-0.9 (-10.29 %)	2016 Q2
-0.82	-0.8 (1.96 %)	2016 Q1
-0.82	-0.8 (1.96 %)	2015 Q4
-1.22	0 (100 %)	2015 Q3
-0.82	-1.2 (-47.06 %)	2015 Q2
-1.22	-1.6 (-30.72 %)	2015 Q1
-1.22	-1.2 (1.96 %)	2014 Q4
-1.22	-2.4 (-96.08 %)	2014 Q3
-1.63	-1.2 (26.47 %)	2014 Q2
-1.63	-2 (-22.55 %)	2013 Q3
-1.63	-0.8 (50.98 %)	2013 Q2
-0.82	-0.8 (1.96 %)	2013 Q1
-0.82	-0.4 (50.98 %)	2012 Q4
-1.63	-0.8 (50.98 %)	2012 Q3

%-지분	이름	주식	변경
4.93329 %	BlackRock Institutional Trust Company, N.A.	1,361,587	106,194
4.74164 %	The Vanguard Group, Inc.	1,308,694	33,414
3.24122 %	PTC Therapeutics Inc	894,578	-400,000
3.14508 %	Bigger Capital Funds, LP	868,042	121,048
1.77230 %	Geode Capital Management, L.L.C.	489,155	35,156
1.53658 %	Taylor Frigon Capital Management LLC	424,097	71,491
1.47179 %	District 2 Capital LP	406,214	238,860
1.29961 %	Bigger (Michael)	358,692	59,376
1.26412 %	State Street Global Advisors (US)	348,898	21,684
1.20795 %	Brown Advisory	333,395	0
0.95422 %	Burnett (Joseph Michael)	263,364	12,638
0.84153 %	Cahill Wealth Management, LLC	232,263	44,179
0.73040 %	Sentinus, LLC	201,590	50,050
0.72464 %	CM Management, LLC	200,000	0
0.66222 %	Northern Trust Investments, Inc.	182,774	11,666
0.63149 %	Lane Generational, LLC	174,291	24,512
0.58696 %	Winter (Patricia)	162,000	19,000
0.47370 %	Legato Capital Management LLC	130,741	130,741
0.41791 %	Parametric Portfolio Associates LLC	115,344	33,676
0.38468 %	Parsons Capital Management, Inc.	106,173	0
0.30277 %	Calamos Advisors LLC	83,564	83,564
0.27100 %	Fletcher (R John)	74,797	850
0.24272 %	Bridgeway Capital Management, LLC	66,992	0
0.22743 %	Charles Schwab Investment Management, Inc.	62,770	0
0.21461 %	Commonwealth Financial Network	59,232	-9,298
0.20603 %	BlackRock Investment Management, LLC	56,863	-299
0.19943 %	Girin (Pascal E R)	55,044	1,056
0.19568 %	BNY Mellon Asset Management	54,007	157
0.19463 %	Essex Investment Management Company, LLC	53,718	13,425
0.19418 %	D'Alessandro (Danilo)	53,594	4,665
0.19395 %	UBS Financial Services, Inc.	53,531	13,958
0.19226 %	Royce Investment Partners	53,065	53,065
0.18690 %	BlackRock Financial Management, Inc.	51,584	-95
0.17280 %	Stigall (L Jeremy)	47,694	5,709
0.16871 %	Goldman Sachs Asset Management, L.P.	46,564	-718
0.16090 %	Richards (Timothy T)	44,408	1,640
0.15902 %	Sabra (Mazin)	43,889	3,450
0.15621 %	Morgan Stanley & Co. LLC	43,115	9,682
0.12951 %	BofA Global Research (US)	35,744	17,260
0.12935 %	Silvercrest Asset Management Group LLC	35,700	0
0.11757 %	LPL Financial LLC	32,450	1,000
0.11520 %	Nuveen LLC	31,795	0
0.11422 %	Barclays Bank PLC	31,524	27,417
0.10623 %	Jane Street Capital, L.L.C.	29,319	29,319
0.10151 %	Citadel Advisors LLC	28,017	-58,191
0.08353 %	T. Rowe Price International Ltd	23,054	688
0.07642 %	Rhumbline Advisers Ltd. Partnership	21,092	-9,265
0.07540 %	BMO Family Office, LLC	20,811	-6,620
0.07411 %	Johnson (B Kristine)	20,453	0
0.07019 %	1919 Investment Counsel, LLC	19,373	0
0.06822 %	T. Rowe Price Associates, Inc.	18,830	0
0.06611 %	DWS Investments UK Limited	18,246	0
0.06400 %	Susquehanna International Group, LLP	17,663	17,663
0.05963 %	JPMorgan Private Bank (United States)	16,458	16,458
0.05475 %	Northern Trust Global Investments	15,111	-3,533
0.05415 %	J.P. Morgan Securities LLC	14,946	-11,981
0.04847 %	Mirae Asset Global Investments (USA) LLC	13,378	0
0.04758 %	Liau (Linda M. M.D., Ph.D.)	13,131	436
0.04659 %	Virtu Americas LLC	12,858	12,858
0.04658 %	Fallon (Lynnette C)	12,855	0
0.04446 %	Klein (Matthew B)	12,272	0
0.04440 %	MetLife Investment Management, LLC	12,254	0
0.04128 %	SunAmerica Asset Management, LLC	11,394	-47
0.03734 %	Manulife Investment Management (North America) Limited	10,305	0
0.03551 %	Invesco Advisers, Inc.	9,801	-1,335
0.02792 %	Fidelity Management & Research Company LLC	7,706	3,476
0.02681 %	Advisory Services Network, LLC	7,400	7,400
0.02629 %	Mellon Investments Corporation	7,255	1
0.02521 %	Group One Trading, L.P.	6,959	5,897
0.02252 %	Moisand Fitzgerald Tamayo, LLC	6,216	0
0.02181 %	Wells Fargo Bank, N.A.	6,020	1,355
0.01945 %	Voya Investment Management LLC	5,368	0
0.01783 %	AllianceBernstein L.P.	4,920	0
0.01772 %	RBC Wealth Management, International	4,891	1,963
0.01492 %	ProShare Advisors LLC	4,118	760
0.01367 %	California State Teachers Retirement System	3,773	-1,285
0.01216 %	Morgan Stanley Smith Barney LLC	3,355	0
0.01208 %	Citi Investment Research (US)	3,333	3,292
0.01149 %	Amalgamated Bank Institutional Asset Management & Custody	3,171	-230
0.01089 %	Principal Global Investors (Equity)	3,006	0
0.00888 %	Mackenzie Financial Corporation	2,451	-1,078
0.00870 %	Legal & General Investment Management Ltd.	2,400	-321
0.00767 %	Tower Research Capital LLC	2,118	-198
0.00739 %	RBC Capital Partners	2,040	1,327
0.00702 %	Simplex Trading, LLC	1,938	1,938
0.00686 %	Ameritas Investment Partners, Inc.	1,893	0
0.00503 %	DWS Investment Management Americas, Inc.	1,389	-6,278
0.00460 %	Metropolitan Life Insurance Co. (US)	1,270	0
0.00365 %	Franklin Mutual Advisers, LLC	1,008	0
0.00319 %	Adirondack Trust Company	880	0
0.00308 %	City State Bank	850	0
0.00300 %	Osaic Holdings, Inc.	829	-347
0.00281 %	New York State Common Retirement Fund	775	-63
0.00277 %	BMO Capital Markets (US)	765	0
0.00274 %	BNY Mellon Wealth Management	755	-1,177
0.00207 %	Assenagon Asset Management S.A.	571	23
0.00188 %	ProFund Advisors LLC	519	57
0.00144 %	Invesco Capital Management LLC	398	0
0.00118 %	Guggenheim Investments	327	0
0.00109 %	Jamison Private Wealth Management, Inc.	300	0

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Siemens Healthineers	공급업체고객	0,45	0,62	0,63	0,75	0,01	0,30
Clinical Laserthermia Systems B	공급업체고객	0,02	0,17	0,75	0,64	0,33	-0,53
Koninklijke Philips	공급업체고객	0,01	-0,21	0,40	0,49	0,92	0,41
Voyager Therapeutics	공급업체고객	-0,17	0,19	0,59	-0,11	-0,41	-0,59

What values and corporate philosophy does Clearpoint Neuro represent?

Clearpoint Neuro Inc represents values of innovation, patient-focused care, and collaboration in the field of neurosurgery and neuromodulation. The company strives to improve patient outcomes by developing advanced technologies and solutions tailored to meet the unique needs of neurosurgeons. Clearpoint Neuro is dedicated to providing precision-guided therapies and enabling targeted delivery of therapies to the brain. Their corporate philosophy emphasizes the importance of cutting-edge research, strategic partnerships, and continuous improvement to drive advancements in neurological treatments. With a commitment to excellence, Clearpoint Neuro aims to make a significant impact in the lives of patients suffering from neurological disorders.

In which countries and regions is Clearpoint Neuro primarily present?

Clearpoint Neuro Inc is primarily present in the United States.

What significant milestones has the company Clearpoint Neuro achieved?

Clearpoint Neuro Inc has achieved several significant milestones. The company established itself as a leader in the field of neurosurgery by developing and commercializing a unique and innovative MRI-guided neurosurgical system called Clearpoint. This system allows precise and real-time guidance for brain surgeries, enhancing patient outcomes and reducing risks. In addition, Clearpoint Neuro Inc has successfully obtained regulatory clearances for its products in multiple countries, expanding its global reach. The company has also formed strategic partnerships with renowned medical institutions and received recognition for its advancements in neurosurgery. Clearpoint Neuro Inc continues to make advancements in the field, solidifying its position as a trusted provider of innovative neurosurgical solutions.

What is the history and background of the company Clearpoint Neuro?

Clearpoint Neuro Inc is a medical technology company specializing in the development and commercialization of devices for neurological procedures. Founded in 1999, Clearpoint Neuro has established itself as a leader in the field of image-guided neurosurgery. The company's innovative platform combines real-time MRI technology with surgical planning software, enabling precise targeting and accurate delivery of therapies to the brain. Clearpoint Neuro's devices have been utilized in various clinical applications, including the treatment of movement disorders, brain tumors, and epilepsy. With its commitment to advancing neurosurgical interventions, Clearpoint Neuro continues to push the boundaries of neuroscience to improve patient outcomes.

Who are the main competitors of Clearpoint Neuro in the market?

The main competitors of Clearpoint Neuro Inc in the market include companies such as Medtronic, Inc., Stryker Corporation, and Brainlab AG.

In which industries is Clearpoint Neuro primarily active?

Clearpoint Neuro Inc is primarily active in the medical device industry.

What is the business model of Clearpoint Neuro?

Clearpoint Neuro Inc's business model focuses on developing and commercializing innovative medical devices for a variety of neurosurgical procedures. The company primarily specializes in providing advanced technology solutions for neurologists and neurosurgeons, empowering them to precisely deliver therapeutic interventions to the brain. Clearpoint Neuro Inc's flagship product, the ClearPoint Neuro Navigation System, enables real-time MRI-guided neurosurgery, enhancing accuracy and patient outcomes. By combining imaging technology with surgical instruments, the company aims to revolutionize neurosurgical procedures. Clearpoint Neuro Inc's business model revolves around providing cutting-edge solutions that improve the precision, safety, and efficacy of neurosurgical interventions, ultimately benefiting patients and healthcare professionals alike.

Clearpoint Neuro 2024의 P/E 비율은 얼마입니까?

Clearpoint Neuro의 P/E 비율은 -17.51입니다.

Clearpoint Neuro 2024의 KUV는 얼마입니까?

Clearpoint Neuro의 P/S 비율은 10.36입니다.

Clearpoint Neuro의 AlleAktien 품질 점수는 얼마인가요?

Clearpoint Neuro에 대한 AlleAktien 품질 점수는 7/10입니다.

Clearpoint Neuro 2024의 매출은 얼마인가요?

예상되는 Clearpoint Neuro 매출은 31.95 백만 USD입니다.

Clearpoint Neuro 2024의 이익은 얼마인가요?

예상되는 Clearpoint Neuro 이익은 -18.91 백만 USD입니다.

Clearpoint Neuro은 무엇을 하나요?

Clearpoint Neuro Inc. is an innovative company in the field of medical devices and imaging technologies. The company is headquartered in Irvine, California and operates worldwide. Clearpoint Neuro offers a wide range of solutions for the assessment of brain and central nervous system diseases. Clearpoint Neuro's business model is based on several divisions. On one hand, the company specializes in the development of imaging technologies and surgical instruments for the placement of electrodes and catheters in the brain. This includes the Clearpoint Neuro Navigation System and the SmartFrame®. The Clearpoint Neuro Navigation System allows neurosurgeons to combine electrophysiological and imaging data in real-time during surgical procedures. With the support of this system, neurosurgeons can determine the position of electrodes and catheters more precisely to perform targeted therapies for patients with Parkinson's, epilepsy, and other neurological diseases. The SmartFrame® is an instrument for the placement of catheters and probes in the brain and spine. It provides an extremely precise and reliable method for positioning drug pumps and other instruments for the treatment of pain as well as neurological or psychiatric disorders. In addition, Clearpoint Neuro also offers services such as training medical professionals in the effective use of navigation technology and surgical instruments. A third division of the company is the Clearpoint Neuro Customer Service team. This team provides comprehensive support to customers for any questions related to products and services. It is available for all inquiries and offers training, technical support, and other services. Another important area is the sale of consumables such as catheters and electrodes for electrophysiology. The company has a wide range of high-performance catheters specifically designed for use with the Clearpoint Neuro Navigation System. Clearpoint Neuro also has strategic partnerships with leading medical institutions and research facilities worldwide. These partnerships contribute to the advancement and improvement of Clearpoint Neuro products and provide a platform for future innovations and technologies. In summary, Clearpoint Neuro offers a broad portfolio of products and services for the assessment and treatment of neurological and central nervous system diseases. The company is committed to meeting the needs and requirements of its customers by providing innovative technologies and collaborating closely with its growing customer base.

Clearpoint Neuro 배당금은 얼마입니까?

Clearpoint Neuro은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Clearpoint Neuro이 얼마나 자주 배당을 지급하나요?

Clearpoint Neuro의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Clearpoint Neuro ISIN이 무엇입니까?

Clearpoint Neuro의 ISIN은 US18507C1036입니다.

Clearpoint Neuro WKN은 무엇인가요?

Clearpoint Neuro의 WKN은 A2PZ3E입니다.

Clearpoint Neuro 티커는 무엇인가요?

Clearpoint Neuro의 티커는 CLPT입니다.

Clearpoint Neuro이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Clearpoint Neuro은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Clearpoint Neuro은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Clearpoint Neuro의 배당 수익률은 얼마입니까?

Clearpoint Neuro의 현재 배당 수익률은 입니다.

Clearpoint Neuro의 배당금은 언제 지급되나요?

Clearpoint Neuro은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Clearpoint Neuro의 배당금은 얼마나 안전한가요?

Clearpoint Neuro은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

Clearpoint Neuro의 배당금은 얼마입니까?

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Clearpoint Neuro이(가) 속해 있는 섹터는 어디인가요?

Clearpoint Neuro은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Clearpoint Neuro kaufen, um die vorherige Dividende zu erhalten?

Clearpoint Neuro의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Clearpoint Neuro의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Clearpoint Neuro의 2023년도 배당금은 얼마였습니까?

2023년에 Clearpoint Neuro는 0 USD를 배당금으로 지급했습니다.

Clearpoint Neuro는 어떤 화폐로 배당금을 지급하나요?

Clearpoint Neuro의 배당금은 USD에 지급됩니다.

Scope 1 - 직접 방출	—
스코프 2 - 구매한 에너지로부터의 간접적인 배출	—
Scope 3 - 가치 창출 체인 내의 간접 배출	—
총 CO₂ 배출량	—
CO₂ 감소 전략	✅
석탄 에너지	❌
원자력	❌
동물 실험	❌
펠츠 & 레더	—
살충제	—
팜 오일	—
담배	❌
유전자 변형 생물체	❌
기후 개념	—
지속 가능한 임업	—
재활용 규정	❌
환경 친화적인 포장	❌
위험물질	❌
연료 소비량과 효율성	❌
물 사용량 및 효율성	❌

여성 직원 비율	—
관리 직위에서의 여성 비율	—
아시아 직원 비율	—
아시아 경영진 비율	—
히스패닉/라티노 직원 비율	—
히스패닉/라티노 관리 부문 지분	—
흑인 직원 비율	—
블랙 매니지먼트 지분	—
흰색 종업원의 비율	—
화이트 매니지먼트 지분	—
성인 콘텐츠	❌
알코올	❌
무기	—
총기	❌
도박	❌
군사 계약	❌
인권 개념	❌
개인정보 보호 정책	—
작업 및 건강 보호	❌
카톨릭	✅

환경 보고	❌
이해관계자 참여	❌
콜백 정책	❌
카르텔법	❌

Clearpoint Neuro 티커	Clearpoint Neuro FIGI
CLPT:US	BBG000Q39HV3
CLPT:UA	BBG000Q39J94
CLPT:UC	BBG000Q39K37
CLPT:UN	BBG000Q39KR1
CLPT:UP	BBG000Q39KW5
CLPT:UB	BBG000Q39M24
CLPT:UM	BBG000Q39N22
CLPT:UX	BBG000Q39NQ6
CLPT:UR	BBG000Q39P27
CLPT:UD	BBG000Q39RN0
CLPT:UF	BBG000Q39TS1
CLPT:VY	BBG000Q39V42
CLPT:VJ	BBG000Q39VQ8
CLPT:VK	BBG000Q39W13
CLPT:VF	BBG00DJGQP10
CLPT:VG	BBG00X1P0N27
CLPT:VP	BBG00X1SG3Q2
CLPTUSD:EO	BBG01F5VG2V5
CLPTUSD:X2	BBG01F5VG2W4
CLPTUSD:XH	BBG01F5VG2Y2
CLPTUSD:XF	BBG01F5VG325
CLPTUSD:XE	BBG01F5VG343
CLPTUSD:XJ	BBG01F5VG352
CLPTUSD:XL	BBG01F5VG361
CLPTUSD:XG	BBG01F5VG370
CLPTUSD:XO	BBG01F5VG389
CLPTUSD:XA	BBG01F5VG3D3
CLPTUSD:E1	BBG01F5VG3F1
CLPTUSD:XT	BBG01F5VG3G0
CLPTUSD:XW	BBG01F5VG3H9
CLPTUSD:XU	BBG01F5VG3J7
CLPTUSD:XY	BBG01F5VG3K5
CLPTUSD:XV	BBG01F5VG3L4
CLPTUSD:XM	BBG01F5VG3M3
CLPTUSD:XQ	BBG01F5VG3N2
CLPTUSD:XX	BBG01F5VG3P0
CLPTUSD:XZ	BBG01F5VG3Q9
CLPTUSD:X1	BBG01F5VG3S7
CLPTUSD:EU	BBG01F5VG405

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0	0	0	1	2	2	3	5	3	3	4	5	7	7	11	12	16	20	23	31	39	59
-	-	-	-	100.00	-	50.00	66.67	-40.00	-	33.33	25.00	40.00	-	57.14	9.09	33.33	25.00	15.00	34.78	25.81	51.28
-	-	-	100.00	100.00	100.00	100.00	80.00	66.67	33.33	50.00	60.00	57.14	57.14	63.64	75.00	68.75	65.00	56.52	-	-	-
0	0	0	1	2	2	3	4	2	1	2	3	4	4	7	9	11	13	13	0	0	0
0	-1	-3	-5	-7	-9	-5	-4	-7	-9	-7	-7	-6	-5	-4	-6	-13	-16	-22	-19	-18	-15
-	-	-	-500.00	-350.00	-450.00	-166.67	-80.00	-233.33	-300.00	-175.00	-140.00	-85.71	-71.43	-36.36	-50.00	-81.25	-80.00	-95.65	-61.29	-46.15	-25.42
0	0	-3	-5	-7	-9	-8	-5	-7	-4	-8	-8	-7	-6	-5	-6	-14	-16	-22	-18	-17	-14
-	-	-	66.67	40.00	28.57	-11.11	-37.50	40.00	-42.86	100.00	-	-12.50	-14.29	-16.67	20.00	133.33	14.29	37.50	-18.18	-5.56	-17.65
0.12	0.12	0.13	0.13	0.13	0.17	0.4	1.01	1.43	1.48	1.88	2.75	7.74	10.93	13.16	15.85	20.73	24.18	24.61	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

한 눈에 저평가된 주식을 인식하세요 fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

가격

가격

티커CLPT

ISINUS18507C1036

WKNA2PZ3E

Clearpoint Neuro 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Clearpoint Neuro 주가 이력

Clearpoint Neuro 주식 매출, EBIT, 이익 US18507C1036 · A2PZ3E

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Clearpoint Neuro 매출, 이익 및 EBIT 역사

Clearpoint Neuro 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Clearpoint Neuro 주식 마진 US18507C1036 · A2PZ3E

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Clearpoint Neuro 마진 역사

Clearpoint Neuro 주식 매출, EBIT, 주당 순이익 US18507C1036 · A2PZ3E

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Clearpoint Neuro 매출, 이익 및 EBIT 주당 역사

Clearpoint Neuro 주식 및 주식 분석

Clearpoint Neuro 매출 세분화 US18507C1036 · A2PZ3E

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

Clearpoint Neuro 매출 세분화

Clearpoint Neuro Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Clearpoint Neuro 역사적인 P/E, EBIT 및 P/S에 따른 평가

Clearpoint Neuro 주식 수량 US18507C1036 · A2PZ3E

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Clearpoint Neuro 주식 분할

Clearpoint Neuro 수익 예상

Clearpoint Neuro 수익 놀라움

Eulerpool ESG Scorecard© Clearpoint Neuro 주식을 위해

Eulerpool World ESG Rating (EESG©)

37/ 100

🌱 Environment

한 눈에 저평가된 주식을 인식하세요
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

티커
CLPT

ISIN
US18507C1036

WKN
A2PZ3E